XML 19 R6.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Previously Reported
Revision of Prior Period, Reclassification, Adjustment
Common Stock
Common Stock
Previously Reported
Common Stock
Revision of Prior Period, Reclassification, Adjustment
Treasury Stock
Treasury Stock
Previously Reported
Treasury Stock
Revision of Prior Period, Reclassification, Adjustment
Additional Paid-in Capital
Additional Paid-in Capital
Previously Reported
Additional Paid-in Capital
Revision of Prior Period, Reclassification, Adjustment
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
Previously Reported
Convertible Redeemable Preferred stock, beginning balance (in shares) at Mar. 31, 2019 7,752,515   7,752,515                          
Convertible Redeemable Preferred Stock, beginning balance at Mar. 31, 2019 $ 59,897   $ 59,897                          
Convertible Redeemable Preferred Stock, ending balance (in shares) at Mar. 31, 2020 7,752,515                              
Convertible Redeemable Preferred Stock, ending balance at Mar. 31, 2020 $ 59,987                              
Shares outstanding, beginning balance (in shares) at Mar. 31, 2019         44,803,937 5,124,896 39,679,041 0 (259,953) 259,953            
Beginning balance at Mar. 31, 2019 (105,992) $ (121) $ (105,992) $ 0 $ 0 $ 0   $ 0 $ (4,755) $ 4,755 $ 11,082 $ 15,837 $ (4,755) $ (117,074) $ (121) $ (117,074)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net loss (31,368)                         (31,368)    
Issuance for stock options exercised (in shares)         430,125                      
Issuance for stock options exercised 277                   277          
Vesting of restricted stock units (in shares)         197,722                      
Vesting of restricted stock units 271                   271          
Stock-based compensation 1,546                   1,546          
Shares outstanding, ending balance (in shares) at Mar. 31, 2020         45,431,784     0                
Ending balance at Mar. 31, 2020 $ (135,387)       $ 0     $ 0     13,176     (148,563)    
Convertible Redeemable Preferred Stock, ending balance (in shares) at Mar. 31, 2021 7,752,515                              
Convertible Redeemable Preferred Stock, ending balance at Mar. 31, 2021 $ 59,987                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net loss (31,391)                         (31,391)    
Issuance for stock options exercised (in shares)         2,337,538                      
Issuance for stock options exercised 1,215                   1,215          
Restricted shares vesting (in shares)         306,084                      
Restricted shares vesting 1,098                   1,098          
Stock-based compensation 5,424                   5,424          
Modification of a Warrant 80                   80          
Repurchase of Common Stock (in shares)         (3,629)                      
Repurchase of Common Stock (9)                   (9)          
Shares outstanding, ending balance (in shares) at Mar. 31, 2021         48,071,777     0                
Ending balance at Mar. 31, 2021 $ (158,970)       $ 0     $ 0     20,984     (179,954)    
Increase (Decrease) in Temporary Equity [Roll Forward]                                
Conversion of Preferred Shares (in shares) (7,752,515)                              
Conversion of Preferred Stock $ (59,987)                              
Net equity infusion from the Merger (in shares) 0                              
Net equity infusion from the Merger $ 0                              
Convertible Redeemable Preferred Stock, ending balance (in shares) at Mar. 31, 2022 0                              
Convertible Redeemable Preferred Stock, ending balance at Mar. 31, 2022 $ 0                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net loss $ (68,299)                         (68,299)    
Issuance for stock options exercised (in shares) 7,322,815       7,322,814                      
Issuance for stock options exercised $ 3,300                   3,300          
Issuance for warrants exercised (in shares)         1,931,621                      
Issuance for warrants exercised 1,019                   1,019          
Restricted shares vesting (in shares)         7,307                      
Restricted shares held for taxes (in shares)         (20,546)                      
Restricted shares held for taxes (222)                   (222)          
Cumulative translation adjustment 0                         0    
Stock-based compensation 17,861                   17,861          
Conversion of Preferred Stock (in shares)         7,752,515                      
Conversion of Preferred Stock 59,987                   59,987          
Conversion of Convertible Notes (in shares)         1,135,713                      
Conversion of Convertible Notes 12,128                   12,128          
PIPE Issuance (in shares)         20,000,000                      
PIPE Issuance 200,000                   200,000          
Net equity infusion from the Merger (in shares)         89,088,942                      
Net equity infusion from the Merger 150,257       $ 1           150,256          
Shares outstanding, ending balance (in shares) at Mar. 31, 2022         175,290,143     0                
Ending balance at Mar. 31, 2022 $ 217,061       $ 1     $ 0     $ 465,313     $ (248,253)